Australia may be the first country to eliminate cervical cancer, but the inequality remains.

Published Date: 08 Mar 2023

Australia has the potential to become the first country in the world to eliminate cancer as a public health problem.

Read Full News

Latest News

Magnesium Sulfate Timing in Preterm Delivery Misses Mark

Among patients receiving magnesium sulfate for fetal neuroprotection, only 23% deliver within 24 hours of initial administration.

Add-On Lumateperone Tied to Improved Sexual Function in MDD

Adding lumateperone to antidepressant therapy is linked to a clinically meaningful improvement in sexual dysfunction in patients with major depressive disorder in a new study.

AstraZeneca's Breast Cancer Pill Fails in Late-stage Trial

AstraZeneca's breast cancer pill failed to meet the main goal of improving progression-free survival in a ⁠late-stage trial, the company said on Friday, a week after the...

Mediolateral Episiotomy Cuts Sphincter Injury Risk

Mediolateral episiotomy is associated with a reduction in obstetric anal sphincter injury risk.

EBay Probes How Banned Gender-Test Kits Available in India

EBay has launched an internal review of its shopping website's safeguards after Reuters flagged that several gender-prediction kits were available for delivery to India.

US Names Acting FDA Drug, Vaccine Chiefs to Permanent Posts

The U.S. health department on Tuesday appointed the acting heads of the FDA's drug and biologics review centers to ⁠permanent roles, formalizing leadership at the two key...

Todays Updates

First-Line Combo Therapies Best Chemo Alone in NSCLC Trials

New phase 3 data add to a growing number of EGFR-directed first-line options for advanced NSCLC with EGFR exon 20 insertions.

3D Mammography Improves Long-Term Cancer Risk Prediction

Researchers develop and validate a deep learning model using longitudinal 3D tomosynthesis examinations to predict individualized 5-year risk for breast cancer.

Todays Updates

First-Line Combo Therapies Best Chemo Alone in NSCLC Trials

New phase 3 data add to a growing number of EGFR-directed first-line options for advanced NSCLC with EGFR exon 20 insertions.

3D Mammography Improves Long-Term Cancer Risk Prediction

Researchers develop and validate a deep learning model using longitudinal 3D tomosynthesis examinations to predict individualized 5-year risk for breast cancer.

Latest News

Among patients receiving magnesium sulfate for fetal neuroprotection, only 23% deliver within 24 hours of initial administration.

Adding lumateperone to antidepressant therapy is linked to a clinically meaningful improvement in sexual dysfunction in patients with major depressive disorder in a new study.

AstraZeneca's breast cancer pill failed to meet the main goal of improving progression-free survival in a ⁠late-stage trial, the company said on Friday, a week after the...

Mediolateral episiotomy is associated with a reduction in obstetric anal sphincter injury risk.

EBay has launched an internal review of its shopping website's safeguards after Reuters flagged that several gender-prediction kits were available for delivery to India.

The U.S. health department on Tuesday appointed the acting heads of the FDA's drug and biologics review centers to ⁠permanent roles, formalizing leadership at the two key...

News All Time

Johnson & Johnson Proposes $5.5B Talc Settlement to End Marathon Legal Fight

Remaining lawsuits against the company claim its talc products caused ovarian cancer

What Falling Into the Social Media Vortex Taught Me About My Patients

People aren't "looking" for health information on social platforms, it finds them

Senate Dems Question if RFK Jr.'s Family Will Profit From Vax Settlement

Senators probe HHS Secretary's possible conflicts of interest

CAR T-Cell Therapy in Pregnant Autoimmune Patients: Safe for Baby?

Early data provide reassurance

Opioids for Routine Hysterectomies Really Necessary?

More individualized pain prescriptions should be considered, researcher says

Long-Acting Lenacapavir Still Delivered Effective HIV PrEP After a Year

Only one person developed HIV infection in year-long extensions of two PURPOSE trials

State's Abortion Drug Law Heightens Hemorrhage Risk for Pregnant Patients

Misoprostol in Louisiana is now kept locked in a secure room

Cabotegravir HIV PrEP Effective Among U.S. Women Despite Treatment Interruptions

No cases of incident HIV over more than 1 year of follow-up in OPERA cohort

Experts Establish Pillars of Care for Older Adults With HIV

ART iniitiation, managing comorbidities addressed for aging patients

In Lindsay Clancy's Tragedy, I Recognize Something Painfully Familiar

A better model of care is urgently needed for postpartum mental health

Lindsay Clancy's Diary Chronicled Desperation and 'Brain Fog' Before She Killed Kids

"I want help. I want to be well," her attorney read from one journal entry

A Week After Shaving, She Developed Rare Flesh-Eating Disease

Fournier's gangrene followed a perineal shave and application of cream from an alternative healer

Despite Progress in TNBC, More Biomarkers Are Needed to Improve Outcomes

"PD-L1 is clinically useful but imperfect," expert says

Woman Says She Was Wrongly Diagnosed With Cancer, Had Surgery Due to Labeling Error

Atlanta-area patient filed lawsuit against the medical center

Residential Context Matters in Ovarian Cancer Survival

That's especially true for Black women

Debate on Use of SSRIs in Pregnancy Shifting, Experts Say

Researchers push for a focus on shared structured decision-making processes

Recommended News For You

Dementia-like protein buildup found in pancreas cells before cancer develops

Year in Review: Chronic Lymphocytic Leukemia

Mezigdomide Combinations Show Promise in Multiple Myeloma

Study looks into cancer-related harmful communication.

An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.

Antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer

A small rise in cancer was observed following the 1986 Chernobyl accident.

Recommended Articles For You

Precision Risk Mapping in Cancer Prevention Programs 

Case Learning from Acquired Platelet Function Disorders 

Modern Oncology Education in the Era of Targeted Therapies 

Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Clinical trial is testing whether heavy lifting could combat cancer side effects

2.

The most precise research tools for the deadliest blood cancer have been developed.

3.

Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer

4.

Recent research suggests that vitamin supplements may increase the risk of developing cancer.

5.

Taking vitamin D daily decreased cancer mortality, according to a study.

1.

Molecular Matching for Individualized Blood-Disorder Therapy

2.

Cemiplimab: A Revolutionary Drug For Treating Cancer

3.

Emerging Therapies Through Engineered Blood Cell Manufacturing Platforms

4.

Care Coordination in Chronic Anemia: Mechanisms, Clinical Implications, and Emerging Strategies

5.

From Bruises to Blood Clots: Everything You Need to Know about Hematoma 

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

2.

Thromboprophylaxis In Medical Settings

3.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II

5.

When Unexplained Bruising May Require Blood Testing

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot